Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cue Biopharma Inc

Start price
Target price
Perf. (%)
€1.66
03.04.24
€7.39
03.04.25
-56.93%
01.08.24

Piper Sandler 
03.04.24 50%
buy
Establishment Labs Holdings Inc

Start price
Target price
Perf. (%)
€48.40
03.04.24
€55.41
03.04.25
-14.46%
01.08.24

Citigroup Inc. 
03.04.24 50%
buy
SI-BONE Inc

Start price
Target price
Perf. (%)
€14.40
03.04.24
€24.93
03.04.25
-5.56%
01.08.24

Needham & Company LLC 
03.04.24 50%
buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€4.78
03.04.24
€10.16
03.04.25
-26.78%
01.08.24

Piper Sandler 
03.04.24 50%
buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€4.78
03.04.24
€9.25
03.04.25
-26.78%
01.08.24

Oppenheimer Holdings Inc. 
03.04.24 50%
buy
Scholar Rock Holding

Start price
Target price
Perf. (%)
€13.80
03.04.24
€18.50
03.04.25
-39.13%
31.07.24

Truist Financial Co. 
03.04.24 50%
buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€4.78
03.04.24
€16.65
03.04.25
-26.78%
01.08.24

Truist Financial Co. 
03.04.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€62.50
03.04.24
€79.68
03.04.25
17.60%
01.08.24

Royal Bank of Canada 
03.04.24 50%
buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€28.10
03.04.24
-
03.04.25
-13.35%
01.08.24

DirectorDealer 
03.04.24 50%
sell
Accentro Real Estate AG

Start price
Target price
Perf. (%)
€0.89
02.04.24
-
02.04.25
-30.34%
14.04.24

Risky Investment
Wolf_of_WS 
02.04.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.11
02.04.24
-
02.04.25
-38.74%
16.04.24

Could be very worthwhile Investment >20% year
thomasw 
02.04.24 50%
sell
Comstock Resources Inc.

Start price
Target price
Perf. (%)
€8.47
02.04.24
€8.36
02.04.25
-0.64%
01.08.24

The Goldman Sachs Group, Inc. 
02.04.24 50%
buy
Accelerate Diagnostics Inc.

Start price
Target price
Perf. (%)
€0.87
02.04.24
-
02.04.25
34.10%
01.08.24

William Blair 
02.04.24 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.37
02.04.24
€19.50
02.04.25
-20.77%
01.08.24

HC Wainwright 
02.04.24 50%
buy
BioXcel Therapeutics Inc

Start price
Target price
Perf. (%)
€2.44
02.04.24
-
02.04.25
14.60%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.14
02.04.24
-
02.04.25
-28.14%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
buy
Trevena Inc.

Start price
Target price
Perf. (%)
€0.33
02.04.24
€8.37
02.04.25
-42.48%
01.08.24

HC Wainwright 
02.04.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.28
02.04.24
-
02.04.25
-57.57%
01.08.24

Probably not worthwhile Investment
Below average Marketposition
Higher risks for its business
Lokrim 
02.04.24 20%
buy
Stride Inc.

Start price
Target price
Perf. (%)
€57.50
02.04.24
-
02.04.25
20.00%
01.08.24

StockNews.com 
02.04.24 50%
buy
Wabash National Corp.

Start price
Target price
Perf. (%)
€26.40
02.04.24
-
02.04.25
-25.95%
01.08.24

StockNews.com 
02.04.24 50%
buy
AGF Management B Pfd NV

Start price
Target price
Perf. (%)
€5.55
02.04.24
€10.70
02.04.25
-2.32%
01.08.24

Desjardins 
02.04.24 50%
sell
Coeur Mining Inc.

Start price
Target price
Perf. (%)
€3.88
02.04.24
€3.00
02.04.25
15.95%
13.04.24

Probably not worthwhile Investment
High valuation
EBIT decline/stagnation expected
Revenue decline/stagnation expected
kostojunior 
02.04.24 0%
sell
Hypoport SE

Start price
Target price
Perf. (%)
€235.20
02.04.24
€166.00
02.04.25
-4.76%
13.04.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
02.04.24 0%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.60
02.04.24
-
02.04.25
-48.88%
13.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
02.04.24 0%
sell
Hypoport SE

Start price
Target price
Perf. (%)
€234.60
02.04.24
-
02.04.25
13.47%
01.08.24

DirectorDealer 
02.04.24 50%